Jump to main content
eTG Complete
Index
Search
Home
Sexual and Reproductive Health
Sexual difficulties
Erectile dysfunction
Oral phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction
Sexual and Reproductive Health
Contraception
Medical abortion
Infertility
Endometriosis
Hirsutism
Polycystic ovary syndrome
Menstrual disorders
Menopause
Male androgen deficiency
Sexual difficulties
Screening and assessment for sexual difficulties
Low libido in females
Low libido in males
Sexual pain in females
Orgasm difficulties in females
Erectile dysfunction
Introduction to erectile dysfunction
Assessment of erectile dysfunction
Approach to managing erectile dysfunction
Oral phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction
Intermittent dosing of PDE5 inhibitors
Daily dosing of PDE5 inhibitors for erectile dysfunction
Adverse effects of PDE5 inhibitors for erectile dysfunction
Intracavernosal therapy for erectile dysfunction
References
Premature ejaculation
Lactation difficulties
Disorders of puberty
Trans and gender diverse health
Oral phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction
Intermittent dosing of PDE5 inhibitors
Daily dosing of PDE5 inhibitors for erectile dysfunction
Adverse effects of PDE5 inhibitors for erectile dysfunction
